ADB-4en-PINACA

ADB-4en-PINACA is a synthetic cannabinoid that has been identified in illicit products sold as herbal incense or synthetic cannabis. It is a potent agonist of the CB1 receptor and CB2 receptor. The compound was first identified in Japan in 2013.

Chemistry

ADB-4en-PINACA is a member of the aminoalkylindole class of synthetic cannabinoids. It is structurally related to other synthetic cannabinoids such as ADB-PINACA and 5F-ADB. The compound has a 4-enone moiety in its structure, which is uncommon among synthetic cannabinoids.

Pharmacology

ADB-4en-PINACA is a potent agonist of the CB1 and CB2 receptors. The CB1 receptor is primarily located in the brain and is responsible for the psychoactive effects of cannabis. The CB2 receptor is primarily found in the immune system and is involved in immune response and inflammation.

Legal status

ADB-4en-PINACA is a controlled substance in several countries, including Japan, the United States, and the European Union. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act.

See also

• Synthetic cannabinoids
• Cannabinoid receptor
• Controlled Substances Act

ADB-4en-PINACA Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski